What is the equity of Nanobiotix this year?
Nanobiotix has equity of -65.7 M EUR this year.
Nanobiotix Equity 2025
Nanobiotix Equity
-65.7 M EUR
Ticker
NANO.PA
ISIN
FR0011341205
WKN
A1J7EB
In 2025, Nanobiotix's equity was -65.7 M EUR, a 3,465.06% increase from the -1.84 M EUR equity in the previous year.
Nanobiotix Aktienanalyse
What does Nanobiotix do?
Nanobiotix SA is a biotechnology company specializing in the development of nanoparticles used in cancer therapy to increase the effectiveness of radiation therapy. It was founded in 2003 in Paris, France by Dr. Laurent Lévy and his team. The company went public in 2012 and is currently listed on the Euronext Paris exchange. Nanobiotix's business model is based on the production and marketing of nanoparticles called NBTXR3, which enhance the effectiveness of radiation therapy. The company works with various partners to further develop its technology and explore new applications. Nanobiotix has two main divisions: one focused on developing nanoparticles to enhance radiation therapy for cancer, and another dedicated to using nanoparticles as drug carriers. Its flagship product, NBTXR3, is designed specifically for cancer therapy and has shown promising results. Nanobiotix is also working on combining NBTXR3 with immunotherapies to further improve cancer treatment. In summary, Nanobiotix is an innovative company specializing in the development of nanoparticles to enhance radiation therapy for cancer and improve patient treatment. Nanobiotix ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Nanobiotix's Equity
Nanobiotix's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Nanobiotix's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Nanobiotix's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Nanobiotix's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Nanobiotix’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Nanobiotix stock
What was the equity of Nanobiotix compared to the previous year?
The equity of Nanobiotix has increased/decreased by 3,465.06% increased compared to the previous year.
What impact does a high equity have on investors of Nanobiotix?
A high equity is advantageous for investors of Nanobiotix as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Nanobiotix?
A low equity can be a risk for investors of Nanobiotix, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Nanobiotix affect the company?
An increase in equity of Nanobiotix can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Nanobiotix affect the company?
A reduction in equity of Nanobiotix can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Nanobiotix?
Some factors that can affect the equity of Nanobiotix include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Nanobiotix so important for investors?
The equity of Nanobiotix is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Nanobiotix take to change the equity?
To change equity, Nanobiotix can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Nanobiotix pay?
Over the past 12 months, Nanobiotix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nanobiotix is expected to pay a dividend of 0 EUR.
What is the dividend yield of Nanobiotix?
The current dividend yield of Nanobiotix is .
When does Nanobiotix pay dividends?
Nanobiotix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nanobiotix?
Nanobiotix paid dividends every year for the past 0 years.
What is the dividend of Nanobiotix?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nanobiotix located?
Nanobiotix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nanobiotix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nanobiotix from 7/4/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/4/2025.
When did Nanobiotix pay the last dividend?
The last dividend was paid out on 7/4/2025.
What was the dividend of Nanobiotix in the year 2024?
In the year 2024, Nanobiotix distributed 0 EUR as dividends.
In which currency does Nanobiotix pay out the dividend?
The dividends of Nanobiotix are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nanobiotix stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nanobiotix
Our stock analysis for Nanobiotix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanobiotix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
